With autonomous drones becoming and increasingly regular threat, countermeasures become necessary. And this weapon developed ...
Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback